In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | | 0.0% | | | | | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | | 100.0% | | 100.0% | 100.0% | | |
Selling, general and administrative [+] | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.0 | |
Sales and marketing | 0.0 | | 0.0 | | | | |
General and administrative | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.0 | 0.0 |
Other selling, general and administrative | 0.0 | | 0.0 | | | | |
Other operating expenses | | | | | | | 0.0 |
EBIT [+] | -0.3 | -0.5 | -0.4 | -0.4 | -0.4 | 0.0 | 0.0 |
EBIT growth | -27.7% | 20.2% | 788.7% | | | | |
EBIT margin | | 1541.5% | | 1282.9% | 1207.5% | | |
Interest income | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | | |
Interest income | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | | |
Other income (expense), net [+] | -0.1 | 0.1 | 0.4 | 1.0 | 1.2 | | 0.0 |
Gain (loss) on derivative instruments | 0.0 | -0.2 | | | | | |
Change in fair value of warrants | 0.0 | 0.2 | 0.4 | 1.0 | 1.2 | | |
Pre-tax income | -0.3 | -0.3 | 0.0 | 0.6 | 0.8 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -0.3 | -0.3 | 0.0 | 0.6 | 0.8 | 0.0 | 0.0 |
Net margin | | 1040.2% | | -2014.5% | -2648.5% | | |
|
Basic EPS [+] | ($0.09) | ($0.11) | $0.00 | $0.06 | $0.10 | ($0.02) | ($0.02) |
Growth | -2697.9% | -279.7% | -114.5% | -361.6% | | | |
Diluted EPS [+] | ($0.09) | ($0.11) | $0.00 | $0.06 | $0.10 | ($0.02) | ($0.02) |
Growth | -2697.9% | -279.7% | -114.5% | -361.6% | | | |
|
Shares outstanding (basic) [+] | 2.9 | 2.9 | 10.0 | 10.0 | 8.2 | 2.0 | 2.0 |
Growth | -71.4% | -71.3% | 400.0% | 400.0% | | | |
Shares outstanding (diluted) [+] | 2.9 | 2.9 | 10.0 | 10.0 | 8.2 | 2.0 | 2.0 |
Growth | -71.4% | -71.3% | 400.0% | 400.0% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |